Menu
GeneBe

SI

sucrase-isomaltase, the group of Glycoside hydrolase family 31

Basic information

Region (hg38): 3:164978897-165078496

Links

ENSG00000090402NCBI:6476OMIM:609845HGNC:10856Uniprot:P14410AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • congenital sucrase-isomaltase deficiency (Strong), mode of inheritance: AR
  • congenital sucrase-isomaltase deficiency (Strong), mode of inheritance: AR
  • congenital sucrase-isomaltase deficiency (Strong), mode of inheritance: AR
  • congenital sucrase-isomaltase deficiency (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Sucrase-isomaltase deficiency, congenitalARGastrointestinalSucrose and other carbohydrate ingestion results in osmotic diarrhea, and dietary/medical therapy (eg, sucrose-reduced diet, treatment with sacrosidase) can be effectiveGastrointestinal5848222; 6082247; 925457; 3553946; 3807985; 3403721; 1717481; 8648532; 8609217; 8648527; 9932843; 10445568; 10903344; 11340066; 12014995; 14724820; 16329100; 18043509; 19680155; 23103650; 23103652; 23103658

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SI gene.

  • not provided (944 variants)
  • Sucrase-isomaltase deficiency (279 variants)
  • Inborn genetic diseases (63 variants)
  • not specified (11 variants)
  • SI-related condition (9 variants)
  • Congenital sucrose-isomaltase deficiency (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SI gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
8
clinvar
149
clinvar
7
clinvar
164
missense
2
clinvar
429
clinvar
22
clinvar
6
clinvar
459
nonsense
20
clinvar
6
clinvar
26
start loss
1
clinvar
1
frameshift
23
clinvar
1
clinvar
2
clinvar
26
inframe indel
5
clinvar
1
clinvar
6
splice donor/acceptor (+/-2bp)
23
clinvar
23
splice region
34
40
6
80
non coding
18
clinvar
146
clinvar
17
clinvar
181
Total 43 32 463 318 30

Highest pathogenic variant AF is 0.000164

Variants in SI

This is a list of pathogenic ClinVar variants found in the SI region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-164978936-C-T Sucrase-isomaltase deficiency Benign (Jan 13, 2018)343994
3-164979047-TA-T Sucrase-isomaltase deficiency Likely benign (Jun 14, 2016)343995
3-164979133-A-G Sucrase-isomaltase deficiency Uncertain significance (Jan 13, 2018)343996
3-164979145-T-G Sucrase-isomaltase deficiency Uncertain significance (Jan 12, 2018)343997
3-164979164-C-A Sucrase-isomaltase deficiency Benign (Apr 27, 2017)900516
3-164979211-T-C Sucrase-isomaltase deficiency Uncertain significance (Jan 13, 2018)900517
3-164979241-G-A Sucrase-isomaltase deficiency Uncertain significance (Jan 13, 2018)900518
3-164979294-A-G Sucrase-isomaltase deficiency Benign (Jan 12, 2018)343998
3-164979365-T-C Likely benign (Nov 04, 2022)2900097
3-164979380-T-G Likely benign (May 31, 2022)2001478
3-164979382-T-C Uncertain significance (Jun 13, 2022)2005438
3-164979385-G-A Uncertain significance (Aug 16, 2022)1510803
3-164979386-T-A Inborn genetic diseases Uncertain significance (May 09, 2023)2545642
3-164979400-C-T Uncertain significance (Mar 12, 2022)2109591
3-164979400-CAT-C Uncertain significance (Jul 29, 2022)1937683
3-164979418-C-T Uncertain significance (Aug 25, 2021)1406546
3-164979423-C-T SI-related disorder Likely benign (Dec 25, 2023)1549343
3-164979444-A-G Likely benign (Apr 06, 2023)2852871
3-164982223-T-C Likely benign (Aug 17, 2023)1665341
3-164982233-C-T Likely benign (Dec 28, 2023)2956342
3-164982234-A-G Likely benign (Nov 28, 2023)1669402
3-164982253-G-C Sucrase-isomaltase deficiency Benign (Jan 29, 2024)343999
3-164982255-G-A Sucrase-isomaltase deficiency Conflicting classifications of pathogenicity (Jan 31, 2024)902174
3-164982265-A-C Sucrase-isomaltase deficiency • Inborn genetic diseases Uncertain significance (Dec 14, 2023)2627953
3-164982273-C-A Likely benign (Jul 31, 2023)2956162

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SIprotein_codingprotein_codingENST00000264382 4799598
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.94e-603.03e-712541703301257470.00131
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.0810679721.100.000049712024
Missense in Polyphen316328.220.962773998
Synonymous-2.293733211.160.00001663308
Loss of Function1.18991120.8800.000005441344

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002290.00220
Ashkenazi Jewish0.000.00
East Asian0.0004930.000489
Finnish0.0006020.000601
European (Non-Finnish)0.001690.00166
Middle Eastern0.0004930.000489
South Asian0.001850.00180
Other0.0008180.000815

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays an important role in the final stage of carbohydrate digestion. Isomaltase activity is specific for both alpha-1,4- and alpha-1,6-oligosaccharides. {ECO:0000269|PubMed:20356844}.;
Disease
DISEASE: Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]: Autosomal recessive intestinal disorder that is clinically characterized by fermentative diarrhea, abdominal pain, and cramps upon ingestion of sugar. The symptoms are the consequence of absent or drastically reduced enzymatic activities of sucrase and isomaltase. The prevalence of CSID is 0.02 % in individuals of European descent and appears to be much higher in Greenland, Alaskan, and Canadian native people. CSID arises due to post-translational perturbations in the intracellular transport, polarized sorting, aberrant processing, and defective function of SI. {ECO:0000269|PubMed:10903344, ECO:0000269|PubMed:11340066, ECO:0000269|PubMed:14724820, ECO:0000269|PubMed:16329100, ECO:0000269|PubMed:8609217}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Starch and sucrose metabolism - Homo sapiens (human);Carbohydrate digestion and absorption - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Glycogen synthetase deficiency;Glycogenosis, Type III. Cori disease, Debrancher glycogenosis;Mucopolysaccharidosis VI. Sly syndrome;Sucrase-isomaltase deficiency;Glycogenosis, Type IV. Amylopectinosis, Anderson disease;Glycogenosis, Type VI. Hers disease;Starch and Sucrose Metabolism;Digestion of dietary carbohydrate;Digestion;Digestion and absorption;sucrose degradation (Consensus)

Recessive Scores

pRec
0.172

Intolerance Scores

loftool
0.0899
rvis_EVS
0.67
rvis_percentile_EVS
84.62

Haploinsufficiency Scores

pHI
0.0721
hipred
N
hipred_score
0.422
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.586

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sis
Phenotype

Gene ontology

Biological process
carbohydrate metabolic process;polysaccharide digestion
Cellular component
Golgi apparatus;plasma membrane;brush border;integral component of membrane;apical plasma membrane;extracellular exosome
Molecular function
alpha-1,4-glucosidase activity;oligo-1,6-glucosidase activity;sucrose alpha-glucosidase activity;carbohydrate binding